MOXIFLOXACIN HYDROCHLORIDE TABLETS

Solicitation SPE2DP-26-T-4868 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Moxifloxacin Hydrochloride 400 MG tablets. The drug is FDA-regulated and must be supplied in bottles containing 30 tablets each. Key technical requirements include a non-extendable shelf life of 36 months and storage at controlled room temperature while avoiding high humidity. The procurement specifies a delivery timeframe of 5 days after receipt of order, with an original required delivery date of September 4, 2026. Shipping is FOB Destination, with delivery locations including the USS John S McCain (DDG 56) and Fort Drum, New York. Compliance and quality standards are stringent, requiring labeling and marking in accordance with Medical Marking Standard No. 1A, which supersedes MIL-STD-129. Packaging must be commercial and adhere to RP001 DLA Packaging Requirements, with non-hazardous materials following ASTM D3951 and hazardous materials following TQ requirement IP025. The contract incorporates various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow (WAWF) system. Inspection and acceptance will occur at the destination.